Two-staged Approach in Positioning Endobronchial Blockers Without Fiberoptic Guidance
NCT ID: NCT02981537
Last Updated: 2017-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
94 participants
INTERVENTIONAL
2016-10-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Comparison of Two New Bronchial Blockers vs. Double Lumen Tubes in One Lung Ventilation
NCT02983149
Bronchial Blocker for One-lung Ventilation in Cardiac Surgery
NCT02729610
Awake Endotracheal Intubation in Cervical Injury
NCT05619965
Fiberoptic Bronchoscope of Double Lumen Tube and Single Lumen Tube in Patients With Semi-regid Neck Collar.
NCT03392766
Learning Curves of Intubation for Simulated Difficult Airway Scenarios by Manikin: Comparison of Combined Pentax Airwayscope-fiberoptic Bronchoscope and Fiberoptic Bronchoscope Alone
NCT02811562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
two-staged
positioning endobronchial blockers to appropriate bronchus with two-staged methods
two-staged endobronchial blocker insertion
positioning endobronchial blockers in two-staged method
single-staged endobronchial blocker insertion
positioning endobronchial blockers in traditional single-staged method
single-staged
positioning endobronchial blockers with traditional single-staged methods
two-staged endobronchial blocker insertion
positioning endobronchial blockers in two-staged method
single-staged endobronchial blocker insertion
positioning endobronchial blockers in traditional single-staged method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
two-staged endobronchial blocker insertion
positioning endobronchial blockers in two-staged method
single-staged endobronchial blocker insertion
positioning endobronchial blockers in traditional single-staged method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients with lesions involving mainstem bronchi
* patients with anomalies in tracheobronchial tree
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jae-Hyon Bahk, MD, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JH Bahk
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Min S, Yoon S, Han J, Seo JH, Bahk JH. A novel technique of blindly positioning bronchial blockers for one-lung ventilation: a prospective, randomized, crossover study. J Cardiothorac Surg. 2025 Jan 9;20(1):50. doi: 10.1186/s13019-024-03276-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JHBahk_blocker
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.